Reference Values and Reliability of Handgrip Strength Assessment Using a Digital Dynamometer in Healthy Adolescents and Other Populations: A Pilot Observational Study

February 10, 2026 updated by: Alejandro Caña Pino, University of Extremadura

his study aims to establish reference values and examine the reliability of handgrip strength assessment using a digital dynamometer (VALD DynaMo) in healthy adolescents.

Participants will undergo standardized strength evaluations of upper and lower limbs, following international testing guidelines.

Descriptive variables such as age, sex, height, weight, hand dominance, and physical activity level will also be recorded.

The results will contribute to developing normative data and validating the use of portable dynamometry for musculoskeletal health assessment, with potential future applications in clinical populations.

Study Overview

Detailed Description

Muscle strength is a key indicator of musculoskeletal health and functional capacity across the lifespan. Handgrip strength, in particular, is widely recognized as a simple and reliable marker of overall strength and health status.

However, normative reference values vary across populations, and limited data exist for adolescents in local or regional contexts.

This observational study will collect handgrip and lower limb strength data using the VALD DynaMo portable dynamometer. The measurements will follow standardized testing positions (American Society of Hand Therapists protocol) to ensure reliability and comparability.

The project will also serve as a pilot for future research on populations with musculoskeletal, neurological, or oncological conditions, where muscle strength is often compromised.

Participation is voluntary, non-invasive, and without associated risk. All data will be anonymized and stored securely for research purposes only.

Study Type

Observational

Enrollment (Actual)

50

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Badajoz
      • Badajoz, Badajoz, Spain, 06006
        • Facultad de Medicina y Ciencias de la Salud. Avenida de Elvas s/n

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Sampling Method

Non-Probability Sample

Study Population

The study will include healthy adolescent students (initially aged 15-16 years) from local educational centers collaborating with the University of Extremadura.

Participants will undergo non-invasive strength assessments using handheld dynamometry to establish normative reference values.

In future phases, the study population may be expanded to include clinical cohorts (e.g., patients with musculoskeletal, neurological, or oncological pathologies) to explore the applicability of dynamometry in clinical assessment and rehabilitation contexts.

Description

Inclusion Criteria:

  • Healthy adolescents aged 15-16 years (for the current phase).
  • Ability to understand and follow verbal instructions.
  • Written informed consent provided by parent or legal guardian (for minors).
  • Assent given by the adolescent participant.
  • In future extensions: individuals aged 10-80 years, including those diagnosed with musculoskeletal, neurological, or oncological conditions, able to safely perform isometric contractions.

Exclusion Criteria:

  • History of acute or chronic upper or lower limb injury in the last 6 months.
  • Neurological, cardiovascular, or systemic disorders that may limit maximal effort.
  • Current pain, inflammation, or post-surgical condition affecting muscle performance.
  • Cognitive or communication impairments preventing valid testing.
  • Refusal or withdrawal of informed consent at any point.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Healthy Adolescent Group
A single group of healthy adolescents will participate in the study. Each participant will undergo standardized assessments of upper and lower limb muscle strength using digital dynamometry. No treatment or intervention will be applied.

All participants (healthy or clinical) will perform standardized muscle strength tests using the VALD Dynamo® digital dynamometer.

For upper limb assessments, the protocol will follow the American Society of Hand Therapists (ASHT) recommendations (shoulder neutral, elbow 90°, forearm neutral, wrist 0-30° extension, 0-15° ulnar deviation).

Lower limb tests will include validated isometric protocols for major muscle groups (quadriceps, hamstrings, hip abductors/adductors).

Each test will include three maximal voluntary contractions (3 seconds each) with 60 seconds of rest between trials.

Data will be used to analyze intra- and inter-session reliability, normative reference values, and potential clinical applicability.

Clinical Population Group (Future Recruitment)
This group may include participants with musculoskeletal, neurological, or oncological conditions in future phases of the study. The same standardized dynamometry protocol will be applied to compare muscle strength profiles and assess the applicability of the measurement tools in clinical populations.

All participants (healthy or clinical) will perform standardized muscle strength tests using the VALD Dynamo® digital dynamometer.

For upper limb assessments, the protocol will follow the American Society of Hand Therapists (ASHT) recommendations (shoulder neutral, elbow 90°, forearm neutral, wrist 0-30° extension, 0-15° ulnar deviation).

Lower limb tests will include validated isometric protocols for major muscle groups (quadriceps, hamstrings, hip abductors/adductors).

Each test will include three maximal voluntary contractions (3 seconds each) with 60 seconds of rest between trials.

Data will be used to analyze intra- and inter-session reliability, normative reference values, and potential clinical applicability.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Maximal Isometric Muscle Strength (Handgrip and Lower Limb)
Time Frame: Single testing session (baseline).

Peak isometric force (in Newtons or kilograms) recorded using a VALD Dynamo® handheld digital dynamometer.

Measurements will follow standardized positioning protocols recommended by the American Society of Hand Therapists (ASHT) for upper limb and by recent literature for lower limb testing.

Each participant will perform three maximal voluntary contractions per muscle group, with the highest value recorded for analysis. Unit of Measure: Newtons (N) or Kilograms.

Single testing session (baseline).

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Test-Retest Reliability of Muscle Strength Measures. Maximal Isometric Muscle Strength Handgrip
Time Frame: Two sessions separated by 7-14 days.

VALD Dynamo®: Assessment of intra-rater reliability of dynamometry results across two sessions separated by 7-14 days, in a subset of participants and intra-session.

Reliability will be quantified using Intraclass Correlation Coefficients (ICC), Standard Error of Measurement (SEM), and Coefficient of Variation (CV). (%)

Two sessions separated by 7-14 days.
Descriptive Anthropometric and Activity Variables
Time Frame: Collected at baseline (single session).

Age, sex, height, body weight, body mass index (BMI), dominant hand, and self-reported physical activity level (frequency and type of sport practiced per week).

These variables will be analyzed to explore associations with muscle strength outcomes.

Collected at baseline (single session).
Clinical Applicability (Optional Future Arm). Maximal Isometric Muscle Strength (Handgrip)
Time Frame: To be determined in future phases

Comparison of muscle strength (kg) profiles between healthy participants and individuals with musculoskeletal, neurological, or oncological conditions (if included in later phases).

Outcomes will explore between-group differences and responsiveness of the measurement tool in clinical contexts.

To be determined in future phases

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

November 6, 2025

Primary Completion (Actual)

November 6, 2025

Study Completion (Actual)

January 31, 2026

Study Registration Dates

First Submitted

February 3, 2026

First Submitted That Met QC Criteria

February 10, 2026

First Posted (Actual)

February 13, 2026

Study Record Updates

Last Update Posted (Actual)

February 13, 2026

Last Update Submitted That Met QC Criteria

February 10, 2026

Last Verified

February 1, 2026

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Healthy Participants

Subscribe